Quantifying the Pollan Effect: Investigating the Impact of Emerging Psychiatric Interventions on Online Mental Health Discourse
Sachin R. Pendse, Neha Kumar, Munmun de Choudhury
May 11, 2024 DOI: 10.1145/3613904.3642477 (opens in new tab)
Study at a glance
AI-extracted from the abstract| Characteristics | Matched computational analysis |
|---|---|
| Sample size | 676,875 |
| Population | Longform Reddit posts describing psilocybin-containing mushroom use |
| Duration | Spanning a decade |
| Keywords | Psychological intervention Mental health |
| Citations | 6 |
| Key points | Health discourse around psilocybin-containing mushrooms increased following the release of a book and documentary, accompanied by a shift toward sharing emotional and social experiences. |
Abstract
Psychedelic-assisted therapy has shown significant promise in alleviating treatment-resistant mental illness, prompting excitement among people with lived experience of mental illness. The emerging collective perception of psychedelics as tools for mental health has been dubbed the Pollan Effect. We investigate whether the Pollan Effect carries to online community discussions concerning psilocybin-containing mushrooms (PCMs). Through a matched computational analysis of 676,875 longform Reddit posts describing PCM use spanning a decade, we provide evidence of the Pollan Effect in terms of increased health discourse around PCMs following two inception points—release of a book and subsequent documentary on PCMs. We then introduce the notion of a Pollan shift, which we witness through increased collective sharing of emotional and social experiences following the two inception points. Our findings offer insights into how online discourse could be representative of emerging social movements around new psychiatric treatments, and the role of platforms in sensemaking and research.
Citations in the library
Cited by 3
- Qualitative content analysis of expectations in participants with depression about to begin LSD microdosing treatment: Identifying the need for psychedelic expectancy measures. Neuropharmacology December 1, 2025
- Applying the EU Regulatory Framework to Determine the Benefit-Risk Profile of Psychedelics. ACS Pharmacology & Translational Science August 8, 2025
- Psychedelic Ethics Philosophy Compass September 1, 2025
Cites 36
- Psilocybin can occasion mystical-type experiences having substantial and sustained personal meaning and spiritual significance Psychopharmacology July 7, 2006
- Psilocybin with psychological support for treatment-resistant depression: an open-label feasibility study. The Lancet Psychiatry May 17, 2016
- MDMA-assisted therapy for severe PTSD: a randomized, double-blind, placebo-controlled phase 3 study. Nature Medicine June 1, 2021
- Mystical-type experiences occasioned by psilocybin mediate the attribution of personal meaning and spiritual significance 14 months later Journal of Psychopharmacology May 30, 2008
- Safety, Tolerability, and Efficacy of Psilocybin in 9 Patients With Obsessive-Compulsive Disorder The Journal of Clinical Psychiatry November 15, 2006
and 31 more in the library